chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a physician who saw on the internet (using Google) refers to a female patient (school girl) of unknown age. A couple years ago on an unknown date the patient was vaccinated with GARDASIL (dose, route lot # and expiration date unknown) and then developed Tourette's Syndrome. The outcome of the event was unknown. The physician had no further information about this school girl or the name of the website where he saw this report. This is one of several reports received from the same source. Additional information has been requested.
2hr p/vax pt felt nauseated, dizzy & had hot sweats;did not take temp but stated felt feverish;sx lasted about 2 days p/vax;pt did not return to the clinic for care;
I was sick sick for 3 days like I had a flu. I experienced dizziness, fever and chills. I was up most of the night due to fever. My arms were sore and all my joints were aching. I was very sweaty due to fever. On the 2nd day I had a light migraine and my arm was incredibly sore and I was not able to move it. They continued through the 3rd and then the symptoms dissolved.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. The patient was vaccinated with an expired dose of ROTATEQ (lot #, dose and route not reported) approximately on 12-NOV-2012. Other suspect therapies included a dose of ROTARIX (lot #, dose and route not reported). No concomitant medications were reported. The medical assistant reported that she was unsure which product was used for administration, between ROTATEQ or ROTARIX. No adverse effects were noted. Additional information has been requested.
Received Moderna vaccine on 2/4/21; 3/4/21 Tested positive for COVID-19 by PCR on 8/24/21; symptom onset date unknown. Hospitalized for mild to moderate COVID-19 infection, admitted 8/24/21.
Patient received a J&J Vaccine on 04/07/21 then scheduled herself for a pfizer shot at our location.  Pharmacist at location verbally verified if the patient had had any vaccines in the last 4 weeks and patient verified verbally and on consent form that she had not.  Pfizer was then administered.  Upon billing, we found she had previously received J&J.  No actual adverse event reported
This spontaneous report received from patient via the VAERS (Vaccine Adverse Event Reporting System) concerned a 66 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802070, and batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 03-MAR-2021 for prophylactic vaccination. Concomitant medications included atorvastatin for drug used for unknown indication.  On 16-MAR-2021, the patient experienced platelet count decreased. The action taken with covid-19 vaccine ad26.cov2.s was not reported. The outcome of platelet count decreased was not reported. This report was non-serious.
Information has been received from a physician concerning a female patient who on unspecified dates was vaccinated with three doses of GARDASIL respectively. On approximately 29-MAR-2011 ("about 2 weeks ago") the patient experienced vaginal edema after the three doses of GARDASIL. At the time of reporting, the patient's outcome was unknown. The patient sought unspecified medical attention. Additional information has been requested.
I was vaccinating family of 5. It turned out youngest needed FLUMIST. I filled 4 out of 5 syringes. I picked up 3 filled  1 empty syringe. Patient was injected with empty syringe. I saw patient next day no adverse reaction.
PATIENT'S FIRST COVID BOOSTER DOSE WAS ADMINISTERED AT THE INCORRECT INTERVAL OF 14 DAYS INSTEAD OF 4 MONTHS.  DOSE 1 WAS GIVEN 3/3/22 (PFIZER) AND DOSE 2 WAS GIVEN 4/28/22 (PFIZER).
Pt developed redness and swelling at the R anterior thigh at the site of the DTAP. Mother outlined the margins of the erythema this a.m. when she noted same. No progression has occurred. Pt received the injection 36 hours ago.
pt called 12/3 to notify she began to have hives between 5 and 530pm after receiving vaccine approx 238pm.  12/3 am she also had eye swelling.  She has history of hives w benadryl.  Was out in yard on wednesday but thinking it is likely from vaccine, not outside allergies as presentation was thurs night/fri am.  she tried cold compress at home.  RPh referred her to dr due to eye involvement. urgent care gave her steroid shot, oral hydroxyzine, and recommended oral zyrtec.
very bad headache; fever of 101.7 Fahrenheit for temperature; This is a spontaneous report from a Pfizer sponsored program . A contactable consumer (parent) reported that a 15-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported, patient was 15-year-old at the time of vaccination), via an unspecified route of administration on 10Aug2021 at 05:30 PM as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number was not reported), on an unspecified date in 2021 as DOSE 1, SINGLE for covid-19 immunisation. Reported that a day after vaccination at 5:30 PM, after school her son complain that he is having headache and a fever of 101.7 Fahrenheit for temperature. Reporter stated, Yes we got the vaccine last night at about 5:30 no problem at night went to school today, I called him after school his school is 08:30 to 03:00 so, I called him after to check on him the first shot was given several weeks ago and things are very high in (withheld) today and he walks home from school so he tried to take his things to reconsideration so at 3 'O clock he said he had very bad headache so, I said okay so all you can do now is drink a lot of water and lay down and I get off work 5 O' Clock and then I came back home at 5:30. So, I came home 5:30 asked him if he still have the headache. So, I did what I would normally do to cold wash and lay. It was reported that reporter asked if she able to give him Acetaminophen. so, we can try to bring him down or am I not supposed to, I don't know. On 11Aug2021 at 03:00 PM, the patient experienced very bad headache, on 11Aug2021, the patient experienced fever of 101.7 Fahrenheit for temperature. The patient underwent lab tests and procedures which included body temperature: 101.7 Fahrenheit on 11Aug2021. Patient received treatment for event headache. The outcome of events was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Wheezing, difficulty breathing, swollen throat and tongue... Same reaction as when I take aspirin.
This spontaneous report was received from a healthcare student referring to an unspecified patient of unknown age and gender. No concurrent or historical conditions were reported. On 17-NOV-2015, the patient inadvertently received an expired dose of PNEUMOVAX 23 (Lot # K005402, expiration date 07-NOV-2015), dose, route and anatomical location were not reported. No concomitant medication was reported. No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
Sore breasts and nipples; This spontaneous case was reported by a consumer and describes the occurrence of BREAST PAIN (Sore breasts and nipples) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BREAST PAIN (Sore breasts and nipples). At the time of the report, BREAST PAIN (Sore breasts and nipples) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were provided No treatment were provided
FEVER - 99.3°-102.9° SEVERE MUSCLE CRAMPING / PAIN IN BACK, SIDE, RIBS JOINT PAIN LETHARGIC NO APPETITE DEHYDRATION  Pt was taken by ambulance to ER - no relief after administration of Torodol. Norco somewhat helpful. Second trip to ER (different), pt was given IV antibiotics, morphine, CAT scan from upper chest to pelvis MRI next date was unremarkable for infection of lower spine. Dr. states that there is no reason for fever or pain, save the Moderna vaccine
Two days after receiving the vaccine, I started feeling very fatigued to where I came straight home from work and went to bed without eating supper. Shortness of breath that got worse daily, O2 saturation levels kept getting lower sometimes in the 80"s. I saw my PCP on March 10, 2021 and was sent to get a chest x-ray. Called 3/11/2021 to get a chest CT done on 3/12/2021, I called my rheumatolist who wanted to see me in her office 3/12/2021  before I went to get the CT Chest completed which was scheduled for 11am. She had blood drawn in the office before I went to the the CT Chest done.  While in he lobby waiting for the CT results , Dr. nurse called to tell me to go to the Emergency Dept  because my blood level was low. I went to the ER and waited 3 hours before going back to a room.  I was dx with pulmonary hemorrhage, sever anemia and low iron level. My hemoglobin was 7 and iron saturation was 2%.  While waiting in the ER, I received notification  by the principal at one of the schools I serve, I had been  exposed to a student 4 days earlier that tested positive for covid 3/12/2021. I told the doctor and they tested ne for covid which was negative. I was admitted to the hospital 2/12/21-3/17/21.  two of those days in ICU. Had a bronoscopy to remove the blood from my lungs, received rituimab infusions , Iron infusion and high doses of prednisone infusions. Once discharged received more rituximab and iron infusions out pt. In April started having severe back pain, dx with 3 spontaneous fractures in my back. out of work since onset to current. getting PT now
7/23/21  Postive RT-PCR at   Admitted to  Hospital  on 7/31/21 for SOB, Headache, Cough, Myalgia, Diarrhea, Fever, Acute Respiratory Failure, Pneumonia.  Discharged home from hospital on 8/2/21
Right arm fatigue & numbness since booster shot. Right leg fatigue & numbness since booster shot.
Bruises on my thighs, looks like blood clots; Bruises on my thighs, looks like blood clots; This is a spontaneous report from a contactable consumer (patient). A 42-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Left Arm on 17Apr2021 11:00 at the age of 42-years-old as single dose for covid-19 immunisation. Medical history included anaemia, iron deficiency. No known allergies. Patient was not pregnant, not pregnant at time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included iron, other vitamins such as biotin and minerals nos, vitamins nos (PRENATAL VITAMINS) within 2 weeks of vaccination.  The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced bruises on thighs, looked like blood clots on 17Apr2021. No treatment received for the events. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was not recovered. The events assessed as non-serious.  Information on the lot/batch number has been requested.
pt recv vax 25MAY95 & on 9MAR98 pt exp varicella-like rash w/50 lesions;
pt recvd vax 18JUL94 @ 1130AM later lunch was eaten & nap; pt awakened @ 5PM 101.5 fever, fussy; up & down fever used APAP; emesis x 1; crying on & off;
Was given Tdap vaccine Oct 26, 2007, approximately 11-9-07 began to have chest and arm to elbow on left side pain. Went to ER on 11-14-07-CR. heart and was given Toradol 30 mg w/no relief-On 11-16-07 return visit to ER. As he fell and couldn't feel his legs-regained feeling and another inj. of Toradol w/Norelid-Is now on Oxycodone, Valium, Naproxen, Neurontin w/no relief of pain
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Additional Details: swelling in mouth - tongue/throat.  white spots on lip/mouth.  vaccine given 11:07, sx started ~11:17, benadryl given 11:20, EMS arrived 11:34.  Patient was fine and stable, left with husband a few minutes later.  counseled on what to do if symptoms reemerge.
One week after receiving my second dose of Pfizer Covid vaccine, I developed a large red rash on my arm where I received the vaccine.  The rash is slightly painful and sometimes itchy.
Small bite like blister on my left arm/under chin/back/left ankle; Itching; Burning; This case was reported by a consumer via ( Shingrix GSK Chatbot) interactive digital media and described the occurrence of blister in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In December 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced blister, pruritus and burning sensation. On an unknown date, the outcome of the blister was not recovered/not resolved and the outcome of the pruritus and burning sensation were unknown.   It was unknown if the reporter considered the blister, pruritus and burning sensation to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication. The patient received the vaccine and had symptoms that started with small bite like blister on left arm and were currently under the chin and small of back. The patient also had a bit (spit) on left ankle and there was itching and burning. The patient did not have their 2nd dose till the time of reportng.
No adverse events; He had 1st COVID19 (Pfizer) on Jan 27th which was only 7 days apart between two vaccines. CDC recommend separate out at least 14 days.
Prior to 11/26 I noticed a strange sensation in my legs put not pain. More just sore to the touch and nerve sensors were off and my legs were always VERY cold for about a week prior to 11/26. Then in 11/26 Woke up and noticed that most of my face was paralyzed. I could not smile, or close my lips all the way or close my eyes all the way. I went to the hospital where they did all kinds of tests to rule out Bells Palsy. All the tests came back negative but my face slowly got worse and now it was affecting both sides of my face. Could not blink or smile etc. No other symptoms. After 1 week, the symptoms started to go away and I was diagnosed with a rare case of Guillain Barre Syndrome.
Within 15 minutes of vaccine administration, I developed difficult swallowing, scratchy throat and severe flushing of face, neck and chest. This lasted about 1.5 hours. Symptoms resolved within 2 hours. Treated with oral Benadryl and Tylenol
This case was reported by a consumer via call center representative and described the occurrence of sleeplessness in a 75-year-old male patient who received SHINGRIX. The patient's past medical history included Hodgkin's lymphoma. On 11th April 2018, the patient received SHINGRIX .5 ml. On 11th April 2018, 7 hrs after receiving SHINGRIX, the patient experienced sleeplessness, general body pain and fatigue. On 12th April 2018, the patient experienced dry mouth. On an unknown date, the outcome of the sleeplessness, dry mouth, general body pain and fatigue were unknown. It was unknown if the reporter considered the sleeplessness, dry mouth, general body pain and fatigue to be related to SHINGRIX. Additional details were provided as follows: The reporter reported adverse reactions which were experienced by her husband. On 11th April 2018, less than a day after receiving SHINGRIX, the patient experienced general body pain and fatigue. The patient's wife stated that everything that husband was experiencing they were told prior to receiving vaccine that he may experience, but she wanted to report reactions to the company. The patient had denied permission to contact their physician.
Headache; Chest Pressure; Warm Body; Sweats 2 nights while sleeping; Diarrhea; Fatigue.
My son developed a rash around his mouth after receiving this vaccine. It has been almost 3 months and we have been on 2 different medications and it has still not cleared up. This  was the first vaccination that he ever received.  We only gave this vaccine because we forced against our will based on new laws banning religious exemptions.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 11:19 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 11:17 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 63.59 for dose administered on 27-Feb-2021 and 63.67 for dose administered on 27-Mar-2021.  No concomitant medications were reported.  Batch number 014M20A underwent temperature excursion on 27-Feb-2021with temperature 33 to 35 degrees Fahrenheit from 09:00 AM to 11:00 AM. These vials were moved to fridge on 24- Feb-2021 and beyond use date for the vials was reported as 26-Mar-2021. Product moved to clinic on 27-Feb-2021  Batch number 019B21A underwent temperature excursion on 27-Mar-2021 with temperature 35 degrees Fahrenheit from 09:00 AM to 10:00 AM. These vials were moved to fridge on 23- Mar-2021 and beyond use date for the vials was reported as 22-Apr-2021. Product moved to clinic on 27-Mar-2021 Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour. No treatment medications were reported.
Patient began feeling warm at 5:42 pm 10 minutes after receiving the Moderna vaccine.   Knowing she had a history of anaphylaxis to certain food products I began to monitor her closely.  Since she has had reactions before we offered Benadryl 50 mg and she took one by mouth at this time.  She at this point had also started coughing and started developing a rash on her neck and chest.  She was able to talk to and answer questions still at this time.   I checked her blood pressure at 5:46 pm which measured 124/78 mm/Hg and pulse was 74 bpm.  She continued to decline at this point with the rash getting worse on her neck, increased labored breathing and increased coughing to the point she was unable to answer questions.  We had already called 911 at this point and I went ahead and administered an EpiPen dose of 0.3 mg at 5:52 pm.   I checked her blood pressure 5 minutes later which measured 123/68 mm/Hg and pulse was 123 bpm.  She began to improve with her cough slightly and was able to start answer some questions again.   The paramedics arrived at 6:02 pm.  After they assessed her she was taken to the hospital for further evaluation and monitoring.
the first and second dose of Shingrix was administered 5 weeks apart; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a patient who received Herpes zoster (Shingrix) (batch number 393C7, expiry date 25th October 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional detailos were provided as follows: The age at vaccination was not reported. The Intern stated a patient received the first and second dose of Shingrix was administered 5 weeks apart, which led to shortening of vaccination schedule. The reporter stated that, the patient was immunocompetent. The pharmacy Intern unable to provide any vaccine or patient details. The reporter did not consent to follow up.
Severe headache, body aches, chills, difficulty breathing, severe muscle aches, heart rate 140, extremely high blood pressure 158/91, dizzy, weakness, fever 103.7, swelling of throat, etc
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with one dose of improperly stored GARDASIL (dose, frequency and indication, lot # K010574 with expiration date: 08-APR-2017). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Approximately 1 week post-injection (1-7-21), began feeling soreness return to injection site. Upon waking the next morning (1-8-21), site red, swollen, warm to touch, and tender. First drew border around redness at approximately 0845; by 1300, redness increased in diameter and has spread the width of my arm. Tenderness and swelling have increased as well to approximately a 5-6" diameter. Have taken benadryl PO 25 mg. No other treatment/action at this point.
Patient complaint of low grade temperature 99 degrees, body aches, Right arm swollen, red, warm to touch. Advised to take Tylenol and apply cool compress.
Stated she has fainted in the past after getting an injection. Immediately after receiving flu vaccine, patient fainted. Remained in chair. Feet were elevated. Patient responded in less than 40 seconds. Remained seated for 15 minutes. Was alert and cooperative.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On an unknown date the patient was vaccinated with a dose of improperly stored PROQUAD (lot#, expiry date, route unspecified). No further details provided. No PQC involved. Additional information has been requested.
Janssen Covid Vaccine  Middle upper abdomen pain approximately. 24 hours after shot.